Effectiveness of 2-Dose BNT162b2 (pfizer BioNTech) Mrna Vaccine in Preventing SARS-CoV-2 Infection among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022. Ashley L. Fowlkes , Sarang K. Yoon , Karen Lutrick , Lisa Gwynn , Joy Burns , Lauren Grant , Andrew L. Phillips , Katherine Ellingson , Maria Ferraris , Lindsay B. LeClair , Clare Mathenge , Young M. Yoo , Matthew S. Thiese , Lynn B. Gerald , Natasha Schaefer Solle , Zuha Jeddy , Leah Odame-Bamfo , Josephine Mak , Kurt T. Hegmann , Joe K. Gerald , Jezahel S. Ochoa , Mark Berry , Spencer Rose , Julie Mayo Lamberte , Purnima Madhivanan , Felipe A. Pubillones , Ramona P. Rai , Kayan Dunnigan , John T. Jones , Karl Krupp , Laura J. Edwards , Edward J. Bedrick , Brian E. Sokol , Ashley Lowe , Hilary McLeland-Wieser , Krystal S. Jovel , Deanna E. Fleary , Sana M. Khan , Brandon Poe , James Hollister , Joanna Lopez , Patrick Rivers , Shawn Beitel , Harmony L. Tyner , Allison L. Naleway , Lauren E. W. Olsho , Alberto J. Caban-Martinez , Jefferey L. Burgess , Mark G. Thompson , Manjusha Gaglani Morbidity and mortality weekly report（2022）
AI 理解论文
溯源树
样例
